News
StockStory.org on MSN1d
Gilead Sciences (GILD) To Report Earnings Tomorrow: Here Is What To ExpectBiopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what ...
Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...
"The Handmaid's Tale" may be coming to an end, but the world of Gilead is not with a sequel, "The Testaments," in production ...
Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...
WARNING: The following story contains spoilers about the fifth episode of The Handmaid's Tale's sixth and final season, ...
In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...
Analysts have given Gilead Sciences a total of 15 ratings, with the consensus rating being Outperform. The average one-year ...
Gilead Sciences and Sophia Forum, a London-based charity, have launched a campaign to improve HIV care and outreach for women ...
1d
GlobalData on MSNGilead reports topline data from Phase III trial of Trodelvy combo therapyGilead Sciences has reported positive topline data from the randomised Phase III ASCENT-04/KEYNOTE-D19 trial of Trodelvy ...
1d
Dexerto on MSNThe Handmaid’s Tale Season 6 Episode 5 recap: June makes a deadly return to GileadIn The Handmaid’s Tale Season 6 Episode 5, ‘Janine’, Moira, June, and Luke head to Gilead, and things get deadly.
With tensions on the rise as the series heads towards the midpoint, here's what the remaining schedule of 'The Handmaid’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results